Effect of IV ferric carboxy maltose for moderate/severe anemia: a systematic review and meta-analysis.

ABSTRACT:

Introduction

Anemia remains a prevalent global health issue with varying severity. Intravenous iron supplementation, particularly with ferric carboxymaltose (FCM), has appeared as a possible therapeutic intervention for individuals with moderate to severe anemia. The study aimed to assess the efficacy and safety of ferric carboxymaltose (FCM) in reducing anemia.

Methods

We searched electronic databases, registries, websites, e-libraries, reference lists of reviews, citations, etc. We included randomized control trials (RCTs), non-RCTs, and single-arm studies, while observational studies, case series, and case studies were excluded. Two reviewers independently screened the studies and extracted the data. We included studies of moderate-to-severely anemic Indians and excluded

SUBMITTER: Khatib MN 

PROVIDER: S-EPMC10884292 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature